Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.64 -0.15 (-8.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Accounts Payables (2012 - 2026)

Updated

Processa Pharmaceuticals' Accounts Payables came in at $1.66 million for Q2 2026, up 111.2% from $785,754 a year earlier and up 97.5% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Accounts Payables (2012 - 2026) Analysis & Trends

At the end of FY2025, Processa Pharmaceuticals' Accounts Payables was $1.06 million, up 20.0% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $880,880 in FY2024 (+182.7%), $311,617 in FY2023 (-4.9%), $327,548 in FY2022 (+49.6%) and $218,905 in FY2021 (-31.7%).
  • The Q2 2026 figure represents the highest quarterly Accounts Payables since Q2 2017.
  • Year-over-year, Accounts Payables has increased for four consecutive quarters, with growth averaging 59.7% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q2 2024 (growth of 298.7%), and the weakest in Q2 2023 (a decline of 63.1%).
  • Business Quant data shows PCSA's Accounts Payables at $840,370 (Q1 2026), $1.06 million (Q4 2025) and $727,172 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Processa Pharmaceuticals 4.92 Mn 4.92 Mn - 1.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Mn
Mar 31, 2026 840,370.00
Dec 31, 2025 1.06 Mn
Sep 30, 2025 727,172.00
Jun 30, 2025 785,754.00
Mar 31, 2025 552,560.00
Dec 31, 2024 880,880.00
Sep 30, 2024 711,710.00
Jun 30, 2024 953,086.00
Mar 31, 2024 455,368.00
Dec 31, 2023 311,617.00
Sep 30, 2023 346,299.00
Jun 30, 2023 239,022.00
Mar 31, 2023 316,709.00
Dec 31, 2022 327,548.00
Sep 30, 2022 311,066.00
Jun 30, 2022 648,104.00
Mar 31, 2022 316,092.00
Dec 31, 2021 218,905.00
Sep 30, 2021 354,977.00
API Access

Processa Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=PCSA&period=max&api_key=YOUR_API_KEY